BioLargo, Inc. BLGO
Set alert
0.07 USD 0.00 0.00%
At close · Oct 30
0.062 Day range 0.067
0.06 52-week range 0.20
- YTD
- -61.11%
- 1 year
- -56.25%
- Open
- 0.065
- Prev close
- 0.07
- Mkt cap
- 23.43M
- Vol
- 176.54K
- Avg vol
- 409.55K
- EPS
- -0.05
- P/E
- 0.00
More statistics
- Low
- 0.062
- High
- 0.067
3M chart
Signals (20)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 29, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 28, 2026 | 4 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 5 days ago |
| MACD: Sell Signal | Oct 15, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
| RSI: Oversold | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| SMA: Bullish | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 24, 2026 | 2 months ago |
| RSI: Oversold | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 12, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 6, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 5, 2026 | 2 months ago |
News
- BioLargo Subsidiary Clyra Medical to Exhibit at SAWC Fall 2026 in Las Vegas
- BioLargo, Inc. (BLGO) Q2 2026 Earnings Call Transcript
- BioLargo Canada and Tu Nipi Form Indigenous-Led Partnership to Treat Oil Sands Process Water and More
- BioLargo Townhall and Q2 2026 Earnings Results Webcast and Conference Call on Thursday, September 10th, 2026 - 4:00 PM Eastern Time
- BioLargo's Subsidiary Clyra Medical Adds Third Distribution Channel Accelerating Commercial Rollout of ViaClyr Wound Irrigation Solution
- BioLargo, Inc. to Present at the Inaugural Nasdaq / LD Micro Summit on September 9, 2026
- Critical Review: BioLargo (NASDAQ:BLGO) and Akzo Nobel (OTCMKTS:AKZOD)
- BioLargo to Participate in Gabelli Funds' 4th Annual PFAS Symposium in New York
- Gabelli To Host 4th Annual PFAS Symposium
- BioLargo Reports Second Quarter 2026 Results; Revenue Up 12% Sequentially, Gross Margin Expands to 54%
Your note
Sign in to keep a note on BLGO — it syncs with the Stock Master app.